29 related articles for article (PubMed ID: 21127317)
1. Proton pump inhibitors: potential cost reductions by applying prescribing guidelines.
Cahir C; Fahey T; Tilson L; Teljeur C; Bennett K
BMC Health Serv Res; 2012 Nov; 12():408. PubMed ID: 23163956
[TBL] [Abstract][Full Text] [Related]
2. Bad Medicine: Polypharmacy.
Spence D
Br J Gen Pract; 2017 Dec; 67(665):562. PubMed ID: 29192108
[No Abstract] [Full Text] [Related]
3. A generic system for critiquing physicians' prescriptions: usability, satisfaction and lessons learnt.
Lamy JB; Ebrahiminia V; Seroussi B; Bouaud J; Simon C; Favre M; Falcoff H; Venot A
Stud Health Technol Inform; 2011; 169():125-9. PubMed ID: 21893727
[TBL] [Abstract][Full Text] [Related]
4. [Non-compliance of dyslipaemic patients with electronic prescriptions].
Ruiz García E; Román Cerdán E; García-Jiménez E; Martínez Martínez F
Aten Primaria; 2010 Nov; 42(11):579-80. PubMed ID: 20304530
[No Abstract] [Full Text] [Related]
5. Improving compliance to controlled drug prescription guidelines through the introduction of an EMIS template.
Harbham P; Hussain A; Nair D; Kutty A
Future Healthc J; 2020 Feb; 7(Suppl 1):s35. PubMed ID: 32455274
[No Abstract] [Full Text] [Related]
6. [Not Available].
Gorfinkel I; Brown A; Lexchin JR
Can Fam Physician; 2020 Oct; 66(10):e251-e254. PubMed ID: 33077464
[No Abstract] [Full Text] [Related]
7. Engaging physicians to prescribe more cost-effectively: Blueprint for change.
Gorfinkel I; Brown A; Lexchin JR
Can Fam Physician; 2020 Oct; 66(10):723-725. PubMed ID: 33077447
[No Abstract] [Full Text] [Related]
8. The prescription of lidocaine patches in osteoarthritis-a complete audit cycle.
Mc Colgan R; Dalton DM; O'Sullivan HP; Sproule JA
Ir J Med Sci; 2019 May; 188(2):525-530. PubMed ID: 30066214
[TBL] [Abstract][Full Text] [Related]
9. Giving formulary and drug cost information to providers and impact on medication cost and use: a longitudinal non-randomized study.
Tseng CW; Lin GA; Davis J; Taira DA; Yazdany J; He Q; Chen R; Imamura A; Dudley RA
BMC Health Serv Res; 2016 Sep; 16(1):499. PubMed ID: 27654857
[TBL] [Abstract][Full Text] [Related]
10. Perspectives of physicians practicing in low and middle income countries towards generic medicines: a narrative review.
Hassali MA; Wong ZY; Alrasheedy AA; Saleem F; Mohamad Yahaya AH; Aljadhey H
Health Policy; 2014 Sep; 117(3):297-310. PubMed ID: 25129135
[TBL] [Abstract][Full Text] [Related]
11. Physician awareness of drug cost: a systematic review.
Allan GM; Lexchin J; Wiebe N
PLoS Med; 2007 Sep; 4(9):e283. PubMed ID: 17896856
[TBL] [Abstract][Full Text] [Related]
12. Electronic notifications about drug substitutes can change physician prescription habits: a cross-sectional observational study.
Zuker A; Heart T; Parmet Y; Pliskin N; Pliskin JS
Med Decis Making; 2011; 31(3):395-404. PubMed ID: 21127317
[TBL] [Abstract][Full Text] [Related]
13. Perceived financial incentives, HMO market penetration, and physicians' practice styles and satisfaction.
Hadley J; Mitchell JM; Sulmasy DP; Bloche MG
Health Serv Res; 1999 Apr; 34(1 Pt 2):307-21. PubMed ID: 10199677
[TBL] [Abstract][Full Text] [Related]
14. Impact of interventions designed to increase market share and prescribing of fexofenadine at HMOs.
Benedetto SR; Sloan AS; Duncan BS
Am J Health Syst Pharm; 2000 Oct; 57(19):1778-85. PubMed ID: 11030030
[TBL] [Abstract][Full Text] [Related]
15. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.
Brufsky JW; Ross-Degnan D; Calabrese D; Gao X; Soumerai SB
Med Care; 1998 Mar; 36(3):321-32. PubMed ID: 9520957
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
